Impact of Prostate Cancer Treatment with Low Dose Rate Brachytherapy on Testosterone: A Retrospective Analysis

D. K. Ebner, A. Amundson, J. F. Burlile,C. R. Choo, B. J. Stish, D. J. Lomas, L. A. Mynderse, B. J. Davis

International journal of radiation oncology, biology, physics（2023）

Cited 0|Views3

No score

Abstract

Testosterone levels have been reported to drop following definitive EBRT owing to excess dose delivery to the testes. On review of our institutional experience in definitive LDR brachytherapy for patients treated without ADT administration, no change in testosterone levels were noted.

Translated text

Key words

low dose rate brachytherapy,prostate cancer treatment,prostate cancer,low dose

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined